Big Tech wants to keep stealing patents-so it's going to war with Big PharmaCongress is reforming the PTAB to protect smaller firms from Big Tech's exploitation through repeated legal challenges.
False USPTO Narratives and the Urgent Need for PTAB ReformThe Senate's approval of PREVAIL marks a significant step towards PTAB reform amidst ongoing debates and concerns.
Big Tech wants to keep stealing patents-so it's going to war with Big PharmaCongress is reforming the PTAB to protect smaller firms from Big Tech's exploitation through repeated legal challenges.
False USPTO Narratives and the Urgent Need for PTAB ReformThe Senate's approval of PREVAIL marks a significant step towards PTAB reform amidst ongoing debates and concerns.
PREVAIL Act Narrowly Moves Forward Despite Concerns About Drug Pricing ImpactThe PREVAIL Act is contentious, particularly regarding its potential impact on drug pricing and challenges to pharmaceutical patents.
A Proposal for Improving the PREVAIL ActThe PREVAIL Act aims to improve patent owner protections by reforming AIA review processes to foster fairness and transparency.